Alnylam Pharmaceuticals EVP Sells 4,391 Shares in February 2026.

Alnylam Pharmaceuticals, Inc. (ALNY) has recently disclosed that EVP Chief R&D Officer Garg Pushkal has executed multiple share sales on February 27, 2026. Specifically, he has sold 127 shares at a price of $328.92 per share, 2,259 shares at $330.73 per share, 1,159 shares at $331.49 per share, 942 shares at $332.48 per share, and 140 shares at $334.39 per share. These transactions bring the total number of shares sold by Garg Pushkal on this date to 4,725.